These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31913969)

  • 21. Complexity of medication use in the Veterans Affairs healthcare system: Part II. Antidepressant use among younger and older outpatients.
    Silkey B; Preskorn SH; Golbeck A; Shah R; Neff M; Jones TL; Choi J
    J Psychiatr Pract; 2005 Jan; 11(1):16-26. PubMed ID: 15650618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening indicators to evaluate the clinical significance of drug-drug interactions in polypharmacy among older adults with psychiatric disorders: a delphi study.
    Liu Y; Li X; Yang M; Ding Y; Ji M
    BMC Psychiatry; 2024 Jun; 24(1):417. PubMed ID: 38834965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.
    Gören Z; J Demirkapu M; Akpinar Acet G; Çali S; Gülçebi Idriz Oğlu M
    Turk J Med Sci; 2017 Feb; 47(1):47-54. PubMed ID: 28263519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantifying the impact of drug-drug interactions associated with opioids.
    Pergolizzi JV
    Am J Manag Care; 2011 Sep; 17 Suppl 11():S288-92. PubMed ID: 21999761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically significant drug interactions with antidepressants in the elderly.
    Spina E; Scordo MG
    Drugs Aging; 2002; 19(4):299-320. PubMed ID: 12038880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
    Sheikh-Taha M; Asmar M
    BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin drug interactions and related adverse reactions: an update.
    Bellosta S; Corsini A
    Expert Opin Drug Saf; 2018 Jan; 17(1):25-37. PubMed ID: 29058944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically Significant Drug-Drug Interactions Involving Medications Used for Symptom Control in Patients With Advanced Malignant Disease: A Systematic Review.
    Kotlinska-Lemieszek A; Klepstad P; Haugen DF
    J Pain Symptom Manage; 2019 May; 57(5):989-998.e1. PubMed ID: 30776538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS drug development: Part II: Advances from the 1960s to the 1990s.
    Preskorn SH
    J Psychiatr Pract; 2010 Nov; 16(6):413-5. PubMed ID: 21107146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
    Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
    BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece.
    Spanakis M; Ioannou P; Tzalis S; Chouzouri F; Patelarou E; Kofteridis DP; Antoniou KM; Schiza SE; Patelarou A; Tzanakis N
    Adv Respir Med; 2023 Feb; 91(1):74-92. PubMed ID: 36825942
    [No Abstract]   [Full Text] [Related]  

  • 34. Polypharmacy in Psychiatry: An In-depth Examination of Drug-drug Interactions and Treatment Challenges.
    Shekho D; Mishra R; Kamal R; Khurana D; Chauhan A; Awasthi A
    Curr Pharm Des; 2024; 30(21):1641-1649. PubMed ID: 38798217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
    Schrecker J; Puet B; Hild C; Schwope DM
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder.
    Schoretsanitis G; de Leon J; Eap CB; Kane JM; Paulzen M
    CNS Drugs; 2019 Dec; 33(12):1201-1222. PubMed ID: 31776871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
    Barkin RL; Schwer WA; Barkin SJ
    Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.
    Wang Y; Bahar MA; Jansen AME; Kocks JWH; Alffenaar JC; Hak E; Wilffert B; Borgsteede SD
    J Antimicrob Chemother; 2019 Oct; 74(10):2848-2864. PubMed ID: 31127283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.